Can Cervicitis Cause an Abnormal Pap Smear or HPV Test?
At a Glance
Chronic cervicitis can make cervical cells look mildly abnormal or make a Pap sample hard to read, but it does not cause a false-positive high-risk HPV test. Abnormal results still need follow-up based on the Pap result, HPV type, age, and screening history.
In this answer
3 sections
Yes, chronic cervicitis can sometimes cause an abnormal Pap smear by creating inflammation that makes your cervical cells look irregular. However, an abnormal Pap or a positive HPV test should never be brushed off as “just inflammation.” While inflammation can complicate reading the cells, it does not cause a false-positive HPV test. If your screening results are abnormal, your health care professional will use specialized guidelines to determine whether you need a repeat test, a closer look with a colposcopy, or routine follow-up.
Note: An abnormal Pap smear or a positive HPV test does not mean you have cervical cancer. Most abnormal results are due to early, manageable changes or viral infections that often clear on their own.
How Inflammation Affects Pap Smears
A Pap smear (cytology) involves looking at cervical cells under a microscope to check for abnormal changes. Chronic cervicitis causes persistent inflammation and irritation, which can alter the appearance of your cervical cells [1]. These reactive cellular changes can mimic the cellular damage caused by human papillomavirus (HPV). This overlap can lead to equivocal or mildly abnormal results on your report, such as:
- ASC-US (Atypical Squamous Cells of Undetermined Significance): Mildly abnormal cells with an unclear cause [1].
- LSIL (Low-Grade Squamous Intraepithelial Lesion): Mildly abnormal cells typically associated with an HPV infection [2].
- HSIL (High-Grade Squamous Intraepithelial Lesion): More severely abnormal cells that carry a higher risk of progressing to precancer [3].
However, it is crucial not to assume that an abnormal result is solely due to cervicitis. Research shows that HPV infections and precancerous changes frequently coexist with inflammation [4] [5]. Because cellular changes from inflammation and true precancer can overlap, clinicians cannot simply blame cervicitis for an abnormal Pap smear and dismiss the results.
Does Cervicitis Affect HPV Tests?
Unlike a Pap smear, which looks at the shape of the cells, an HPV test looks for the actual genetic material (DNA or RNA) of high-risk HPV types. Cervicitis and changes in your vaginal microbiome do not cause a false-positive HPV test [6].
If your HPV test is positive, it means detectable high-risk HPV genetic material was found in your sample. It does not mean you have cancer, nor does it tell you when or from whom you acquired the virus. While false positives or invalid results can occasionally happen due to laboratory limitations, sampling issues, or cross-reactivity with low-risk HPV types, they are not caused by cervical inflammation [7] [8]. A positive high-risk HPV result always requires appropriate follow-up, even if you are actively being treated for cervicitis [9].
Do I Need Another Pap After Treatment?
Whether you need to repeat your screening after being treated for cervicitis depends on exactly what your previous results showed. There are two main scenarios based on the 2019 ASCCP (American Society for Colposcopy and Cervical Pathology) guidelines:
1. Your Pap Smear Was “Unsatisfactory”
Sometimes, severe inflammation, mucus, or bleeding from cervicitis can obscure the cells so much that the laboratory cannot properly read the sample. This is called an unsatisfactory specimen.
- If HPV was negative or unknown: The current ASCCP guidance generally recommends repeating your age-based screening as soon as feasible and no later than 4 months [10] [11]. A negative HPV result on an unsatisfactory sample is not considered reassuring, because the sample itself was inadequate [10].
- If high-risk HPV was detected (especially types 16 or 18): These specific types carry a higher risk. Guidelines often recommend going straight to a colposcopy rather than waiting to repeat the Pap [10]. Other high-risk HPV types may also require prompt colposcopy or early repeat testing, depending on your age and history [12].
What is a colposcopy? A colposcopy is an in-office procedure where a clinician uses a special magnifying instrument to closely examine your cervix. If they see suspicious areas, they may take a tiny tissue sample (biopsy) for further testing.
2. Risk-Based Follow-Up (ASCCP Guidelines)
If your Pap smear was successfully read but showed abnormalities, treating the cervicitis does not automatically mean you need a repeat Pap right away just to “check if it cleared up.” Instead, your care team will follow the 2019 ASCCP risk-based management guidelines [13].
These guidelines do not apply a one-size-fits-all timeline. Instead, they calculate your immediate and 5-year risk based on:
- Your exact Pap smear result (e.g., ASC-US, LSIL, HSIL)
- Your HPV test result and specific types (like HPV 16 or 18) [9]
- Your age and prior screening history [14] [15]
Based on your personalized risk profile, your health care professional might recommend short-term surveillance (e.g., repeating the test in 6 to 12 months), a return to routine screening in 1, 3, or 5 years, a colposcopy, or—in rare, high-risk cases—expedited treatment [15] [16]. You should never skip these recommended follow-ups, even if your cervicitis symptoms improve.
Important Caveats: The standard ASCCP guidelines may be modified if you are pregnant, immunosuppressed, under age 25, or have a history of high-grade precancer (CIN2+) or cervical cancer [13] [14].
Safety Note: Screening guidelines are designed for routine monitoring. If you experience severe pelvic pain, heavy or unexplained bleeding, fever, or think you might be pregnant, do not wait for your next screening appointment. Seek medical evaluation promptly.
Common questions in this guide
Can cervicitis make a Pap smear come back abnormal?
Can cervicitis cause a false-positive HPV test?
What should I do if my Pap sample was unsatisfactory because of inflammation?
Do I need another Pap after cervicitis treatment?
What does a positive high-risk HPV result mean?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on chronic cervicitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did my Pap smear show specific cellular abnormalities (like ASC-US or LSIL), or was it marked as 'unsatisfactory' due to inflammation or bleeding?
- 2.Did you test for high-risk HPV types, and if so, what were the exact results?
- 3.Based on my age, current results, and past screening history, what is my ASCCP risk-based recommendation for follow-up?
- 4.Do I need a colposcopy now, or should we repeat my cervical screening after my cervicitis is treated?
- 5.Are there other coexisting infections that we should test for that might be contributing to my symptoms or inflammation?
References
References (16)
- 1
The Pap smear in inflammation and repair.
Kamal MM
CytoJournal 2022; (19()):29 doi:10.25259/CMAS_03_08_2021.
PMID: 35673696 - 2
A Practical Approach to Squamous Abnormalities on Cervical Cytology: Overview of Interpretive Criteria and Guidance for Altering Thresholds in Response to Quality Assurance Findings.
Thrall MJ
Acta cytologica 2023; (67(2)):129-142 doi:10.1159/000528531.
PMID: 36702101 - 3
HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D, Zhang H, Li J, et al.
Journal of the American Society of Cytopathology 2020; (9(6)):550-555 doi:10.1016/j.jasc.2020.04.010.
PMID: 32475726 - 4
A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer.
Salavatiha Z, Farahmand M, Shoja Z, Jalilvand S
Journal of medical virology 2021; (93(8)):4647-4658 doi:10.1002/jmv.26928.
PMID: 33694179 - 5
Cytological versus histological results in ASCUS cervical dysplasia - a retrospective study.
Rokos T, Kudela E, Pribulova T, et al.
Ceska gynekologie 2026; (91(1)):11-15 doi:10.48095/cccg202611.
PMID: 41841534 - 6
The Immunomodulation Role of Vaginal Microenvironment On Human Papillomavirus Infection.
Sun L, Li L, Xu W, Ma C
Galen medical journal 2023; (12()):e2991 doi:10.31661/gmj.v12i0.2991.
PMID: 38827643 - 7
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study.
Preisler S, Rebolj M, Ejegod DM, et al.
BMC cancer 2016; (16()):510 doi:10.1186/s12885-016-2518-4.
PMID: 27439470 - 8
Pitfalls of commercially available HPV tests in HPV68a detection.
Jaworek H, Kubanova K, Koudelakova V, et al.
PloS one 2019; (14(8)):e0220373 doi:10.1371/journal.pone.0220373.
PMID: 31381580 - 9
A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Demarco M, Egemen D, Raine-Bennett TR, et al.
Journal of lower genital tract disease 2020; (24(2)):144-147 doi:10.1097/LGT.0000000000000530.
PMID: 32243309 - 10
HPV Cotesting of Unsatisfactory Papanicolaou Tests: Implications for Follow-up Intervals.
Chen F, Hsu Lin L, Hindi I, et al.
American journal of clinical pathology 2023; (160(2)):137-143 doi:10.1093/ajcp/aqad026.
PMID: 37052613 - 11
Histopathologic Follow-Up of Women with Inadequate ThinPrep™ Cervical Pap Tests and Positive High-Risk Human Papillomavirus Test Results.
Kir G, Ozen S
Acta cytologica 2023; (67(5)):533-538 doi:10.1159/000531957.
PMID: 37494923 - 12
Significance of concurrent HPV testing with unsatisfactory Papanicolaou test for prediction of follow-up HPV, Papanicolaou test, and biopsy results.
Connelly CF, Collins N, Cimic A, Baskota SU
American journal of clinical pathology 2023; (160(5)):444-449 doi:10.1093/ajcp/aqad070.
PMID: 37418598 - 13
Risk-based guidelines: Redefining management of abnormal cervical cancer screening results.
Wiser A, Quinlan JD, Batur P
Cleveland Clinic journal of medicine 2021; (88(10)):556-560 doi:10.3949/ccjm.88a.20193.
PMID: 34598920 - 14
2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.
Cheung LC, Egemen D, Chen X, et al.
Journal of lower genital tract disease 2020; (24(2)):90-101 doi:10.1097/LGT.0000000000000528.
PMID: 32243306 - 15
Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.
Nayar R, Chhieng DC, Crothers B, et al.
Journal of the American Society of Cytopathology 2020; (9(4)):291-303 doi:10.1016/j.jasc.2020.05.002.
PMID: 32565297 - 16
A cohort study of cervical screening using partial HPV typing and cytology triage.
Schiffman M, Hyun N, Raine-Bennett TR, et al.
International journal of cancer 2016; (139(11)):2606-15 doi:10.1002/ijc.30375.
PMID: 27509172
This page explains how cervicitis may affect Pap smear interpretation and HPV testing for educational purposes only. Your health care professional should interpret your results and recommend the appropriate follow-up.